Anavex Life Sciences Corp. Made Headway
Thu, Feb 04, 2021 at 05:30 PM
Anavex Life Sciences Corp. (AVXL:NASDAQ) rocketted at $14.91, a gain of 43.6%. On Wed 03 Feb 21, AVXL:NASDAQ hit a New 2-Week High of $10.38. The stock appeared on our News Catalysts scanner on Thu 04 Feb 21 at 05:03 PM in the 'MISCELLANEOUS' category. From Wed 20 Jan 21, the stock recorded 60.00% Up Days and 63.64% Green Days
About Anavex Life Sciences Corp. (AVXL:NASDAQ)
Anavex Life Sciences Corp is a clinical stage bio-pharmaceutical company. The Company is engaged in the developments drug candidates to treat Alzheimer's disease, other central nervous system (CNS) diseases, and various types of cancer.
Top 10 Gainers:
- ATA Creativity Global (AACG:NASDAQ), 936.23%
- Lizhi Inc. (LIZI:NASDAQ), 70.47%
- CNS Pharmaceuticals, Inc. (CNSP:NASDAQ), 68.27%
- CYTH (CYTH:NASDAQ), 59.39%
- Midatech Pharma plc (MTP:NASDAQ), 47.29%
- Veru Inc. (VERU:NASDAQ), 44.39%
- Meten EdtechX Education Group Ltd. (METX:NASDAQ), 44.21%
- Anavex Life Sciences Corp. (AVXL:NASDAQ), 43.64%
- DAVIDsTEA Inc. (DTEA:NASDAQ), 42.24%
- SANA (SANA:NYSE), 40.4%